<DOC>
	<DOCNO>NCT01918527</DOCNO>
	<brief_summary>The purpose study compare 3 cycle neoadjuvant ( preoperative ) chemotherapy + operation standard treatment locally advanced colon cancer , operation + 8 cycle ( adjuvant ) chemotherapy . Patients receive neoadjuvant chemotherapy may need adjuvant chemotherapy operation , case , spar 5 cycle chemotherapy .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Versus Standard Treatment Patients With Locally Advanced Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically verify locally advanced T3 ( ETI &gt; 5 mm ) T4 colon cancer assess CT scan . Age ≥ 18 year PS 02 . Hematology ANC ≥1.5x10^9/l . Thrombocytes ≥ 100x10^9/l . Biochemistry Bilirubinemia ≤ 3 x upper normal level . ALAT ≤ 5 x upper normal value Consent translational research Fertile woman must present negative pregnancy test use secure contraceptives 3 month treatment . Written orally inform consent . Patients distant metastasis . Acute operation Clinically significant cardiovascular disease ( incl . myocardial infarction , unstable angina , symptomatic congestive heart failure , serious uncontrolled cardiac arrhythmia ) ≤ 1 year inclusion . Active , serious infection serious disease . Peripheral neuropathy NCI grade &gt; 1 Other malignant disease within 5 year prior study enrollment , except basocellular squamous skin cancer carcinoma situ cervicis uterus . Other investigational treatment within 30 day prior treatment start . Hypersensitivity one active auxiliary substance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Locally advanced colon cancer</keyword>
	<keyword>Neoadjuvant chemotherapy</keyword>
</DOC>